|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-1-21
|
|
pubmed:abstractText |
Hexamethylpropyleneamine oxime (HMPAO) SPECT and 18F-FDG PET depict similar aspects of perfusion and metabolic abnormalities in Alzheimer's disease (AD), but the correspondence between them is not known in detail. We therefore used statistical parametric mapping to detect and compare abnormal brain areas objectively and quantitatively.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
21-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11801698-Aged,
pubmed-meshheading:11801698-Alzheimer Disease,
pubmed-meshheading:11801698-Brain,
pubmed-meshheading:11801698-Case-Control Studies,
pubmed-meshheading:11801698-Female,
pubmed-meshheading:11801698-Fluorodeoxyglucose F18,
pubmed-meshheading:11801698-Humans,
pubmed-meshheading:11801698-Male,
pubmed-meshheading:11801698-Radiopharmaceuticals,
pubmed-meshheading:11801698-Technetium Tc 99m Exametazime,
pubmed-meshheading:11801698-Tomography, Emission-Computed,
pubmed-meshheading:11801698-Tomography, Emission-Computed, Single-Photon
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease.
|
|
pubmed:affiliation |
Neurologische Universitätsklinik, Köln, Germany. karl.herholz@pet.mpin-koeln.mog.de
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
